Indalo Therapeutics

About:

A preclinical-stage biotechnology company.

Website: https://indalotherapeutics.com/

Top Investors: F-Prime Capital, BioGenerator, Atlas Venture, Cultivation Capital, Argonautic Ventures

Description:

Indalo Therapeutics is a preclinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating fibrotic diseases. Founded on groundbreaking scientific discoveries and leveraging cutting-edge insight into the molecular drivers of aberrant scarring, Indalo is harnessing the collective experience of a seasoned team of pharmaceutical scientists and executives to tackle some of the most urgent unmet medical needs in the fibrosis space.